Guangzhou Wondfo Biotech Co.,Ltd (SHE: 300482)
China
· Delayed Price · Currency is CNY 20.75
0.00 (0.00%)
Sep 9, 2024, 12:54 PM CST
Guangzhou Wondfo Biotech Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,848 | 2,760 | 5,674 | 3,354 | 2,805 | 2,066 | Upgrade
|
| Other Revenue | 3.29 | 5.22 | 6.89 | 7.11 | 5.82 | 6.71 | Upgrade
|
| Revenue | 2,852 | 2,765 | 5,681 | 3,361 | 2,811 | 2,072 | Upgrade
|
| Revenue Growth (YoY) | -9.06% | -51.33% | 69.01% | 19.57% | 35.64% | 25.59% | Upgrade
|
| Cost of Revenue | 1,060 | 1,040 | 2,747 | 1,396 | 870.75 | 721.01 | Upgrade
|
| Gross Profit | 1,792 | 1,725 | 2,933 | 1,965 | 1,940 | 1,351 | Upgrade
|
| Selling, General & Admin | 881.25 | 877.11 | 1,157 | 910.24 | 819.99 | 655.21 | Upgrade
|
| Research & Development | 384.58 | 378 | 418.84 | 391.09 | 279.43 | 160.44 | Upgrade
|
| Other Operating Expenses | 35.05 | 9.51 | 15.95 | 9.04 | 9.63 | 8.44 | Upgrade
|
| Operating Expenses | 1,315 | 1,268 | 1,609 | 1,330 | 1,115 | 836.26 | Upgrade
|
| Operating Income | 477.27 | 456.73 | 1,324 | 634.64 | 825.49 | 515.05 | Upgrade
|
| Interest Expense | -29.91 | -29.93 | -32.53 | -27.76 | -11.14 | -3.83 | Upgrade
|
| Interest & Investment Income | 40.64 | 58.71 | 64.93 | 50.48 | 40.51 | 1.94 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.97 | 10.99 | 30.58 | -20.62 | -23.62 | 7.95 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.45 | -0.59 | -6.59 | -5.67 | -3.96 | -1.79 | Upgrade
|
| EBT Excluding Unusual Items | 482.58 | 495.91 | 1,381 | 631.08 | 827.28 | 519.31 | Upgrade
|
| Impairment of Goodwill | -3.95 | -3.95 | -38.56 | -5.87 | -71.74 | -37.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | 28.87 | 14.8 | 12.81 | 10.55 | 0.24 | -0.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.14 | 0.08 | -10.4 | -10.34 | -2.51 | -0.94 | Upgrade
|
| Asset Writedown | -0.34 | -0.95 | -29.96 | - | -44.37 | -4.72 | Upgrade
|
| Other Unusual Items | 52.21 | 34.88 | 50.11 | 55.07 | 22.04 | 27.38 | Upgrade
|
| Pretax Income | 559.51 | 540.76 | 1,365 | 680.49 | 730.93 | 503.11 | Upgrade
|
| Income Tax Expense | 46.59 | 53.33 | 174.41 | 47.91 | 114.13 | 76.02 | Upgrade
|
| Earnings From Continuing Operations | 512.92 | 487.43 | 1,190 | 632.58 | 616.81 | 427.1 | Upgrade
|
| Minority Interest in Earnings | -4 | 0.2 | 6.94 | 1.85 | 17.36 | -39.64 | Upgrade
|
| Net Income | 508.92 | 487.62 | 1,197 | 634.43 | 634.17 | 387.46 | Upgrade
|
| Net Income to Common | 508.92 | 487.62 | 1,197 | 634.43 | 634.17 | 387.46 | Upgrade
|
| Net Income Growth | 43.89% | -59.26% | 88.68% | 0.04% | 63.67% | 25.90% | Upgrade
|
| Shares Outstanding (Basic) | 451 | 443 | 442 | 444 | 440 | 442 | Upgrade
|
| Shares Outstanding (Diluted) | 451 | 443 | 442 | 444 | 440 | 442 | Upgrade
|
| Shares Change (YoY) | 2.29% | 0.36% | -0.44% | 0.74% | -0.33% | 1.10% | Upgrade
|
| EPS (Basic) | 1.13 | 1.10 | 2.71 | 1.43 | 1.44 | 0.88 | Upgrade
|
| EPS (Diluted) | 1.13 | 1.10 | 2.71 | 1.43 | 1.44 | 0.88 | Upgrade
|
| EPS Growth | 40.68% | -59.41% | 89.51% | -0.69% | 64.21% | 24.11% | Upgrade
|
| Free Cash Flow | 230.27 | -104.05 | 1,099 | 208.44 | 642.33 | 130.52 | Upgrade
|
| Free Cash Flow Per Share | 0.51 | -0.23 | 2.49 | 0.47 | 1.46 | 0.30 | Upgrade
|
| Dividend Per Share | 0.400 | 0.400 | 0.500 | 0.300 | 0.385 | 0.192 | Upgrade
|
| Dividend Growth | -20.00% | -20.00% | 66.67% | -22.00% | 100.00% | 13.65% | Upgrade
|
| Gross Margin | 62.84% | 62.37% | 51.64% | 58.46% | 69.02% | 65.21% | Upgrade
|
| Operating Margin | 16.74% | 16.52% | 23.31% | 18.88% | 29.37% | 24.85% | Upgrade
|
| Profit Margin | 17.85% | 17.64% | 21.07% | 18.88% | 22.56% | 18.70% | Upgrade
|
| Free Cash Flow Margin | 8.08% | -3.76% | 19.35% | 6.20% | 22.85% | 6.30% | Upgrade
|
| EBITDA | 663.44 | 665.41 | 1,569 | 817.3 | 965.33 | 621.01 | Upgrade
|
| EBITDA Margin | 23.27% | 24.07% | 27.62% | 24.32% | 34.34% | 29.97% | Upgrade
|
| D&A For EBITDA | 186.17 | 208.68 | 244.63 | 182.66 | 139.85 | 105.96 | Upgrade
|
| EBIT | 477.27 | 456.73 | 1,324 | 634.64 | 825.49 | 515.05 | Upgrade
|
| EBIT Margin | 16.74% | 16.52% | 23.31% | 18.88% | 29.37% | 24.85% | Upgrade
|
| Effective Tax Rate | 8.33% | 9.86% | 12.78% | 7.04% | 15.61% | 15.11% | Upgrade
|
| Revenue as Reported | 2,852 | 2,765 | 5,681 | 3,361 | 2,811 | 2,072 | Upgrade
|
| Advertising Expenses | - | - | - | - | 221.25 | 153.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.